Mycoskin (Ciclopirox Olamine)

Ciclopirox Olamine, the active ingredient in Mycoskin, is an antifungal presented as a topical formulation for skin use. It treats superficial fungal infections such as dermatophytosis, tinea pedis, tinea corporis, and candidiasis in adults and children. It is applied to the affected area once or twice daily as directed by a professional.

GNH USA supplies Mycoskin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Mycoskin (ciclopirox olamine) is a topical antifungal used to treat superficial fungal infections of the skin.

Dermatophytosis: reduces fungal growth and clears skin lesions. Tinea pedis: alleviates itching and eliminates the causative dermatophytes. Tinea corporis: resolves ring‑shaped lesions caused by dermatophytes. Candidiasis: treats cutaneous Candida infections and promotes healing.

Topical ciclopirox olamine may cause local skin reactions, most of which are mild and reversible.

Common Side Effects: - Burning sensation: transient mild burning at the application site. - Itching: mild pruritus localized to treated area. - Redness: erythema or mild redness of skin.

Serious or Rare Side Effects: - Contact dermatitis: allergic reaction with swelling and rash. - Severe skin ulceration: rare ulcer formation at application site. - Systemic hypersensitivity: rare systemic allergic response such as urticaria.

When using Mycoskin, certain precautions should be observed to minimize adverse reactions and ensure effectiveness.

- Avoid application on broken skin: do not apply to open wounds or extensive abrasions. - Limit use to indicated areas: restrict treatment to affected skin only. - Monitor for allergic reaction: discontinue if signs of severe irritation or rash develop. - Use as directed by healthcare professional: follow prescribed frequency and duration. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Ciclopirox olamine has a low potential for systemic drug interactions, but certain topical agents may affect its performance.

Major Interactions (Avoid): - Concurrent use with other topical antifungals: may increase irritation risk. - Application with corticosteroid creams: can reduce antifungal efficacy.

Moderate Interactions (Monitor Closely): - Use with occlusive dressings: may enhance absorption and irritation. - Combination with keratolytic agents: may increase local irritation. - Co‑application with sunscreen: monitor for reduced antifungal activity.